AAAAAA

   
Results: 1-8 |
Results: 8
Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation
Authors: Walter, DH Fichtlscherer, S Britten, MB Rosin, P Auch-Schwelk, W Schachinger, V Zeiher, AM
Citation: Dh. Walter et al., Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation, J AM COL C, 38(7), 2001, pp. 2006-2012
Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation
Authors: Walter, DH Fichtlscherer, S Sellwig, M Auch-Schwelk, W Schachinger, V Zeiher, AN
Citation: Dh. Walter et al., Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation, J AM COL C, 37(3), 2001, pp. 839-846
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
Authors: Dimmeler, S Aicher, A Vasa, M Mildner-Rihm, C Adler, K Tiemann, M Rutten, H Fichtlscherer, S Martin, H Zeiher, AM
Citation: S. Dimmeler et al., HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, J CLIN INV, 108(3), 2001, pp. 391-397
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
Authors: Vasa, M Fichtlscherer, S Aicher, A Adler, K Urbich, C Martin, H Zeiher, AM Dimmeler, S
Citation: M. Vasa et al., Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, CIRCUL RES, 89(1), 2001, pp. E1-E7
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
Authors: Vasa, M Fichtlscherer, S Adler, K Aicher, A Martin, H Zeiher, AM Dimmeler, S
Citation: M. Vasa et al., Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease, CIRCULATION, 103(24), 2001, pp. 2885-2890
Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels
Authors: Fichtlscherer, S Zeiher, AM
Citation: S. Fichtlscherer et Am. Zeiher, Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels, ANN MED, 32(8), 2000, pp. 515-518
Elevated C-reactive protein levels and impaired endothelial vasoreactivityin patients with coronary artery disease
Authors: Fichtlscherer, S Rosenberger, G Walter, DH Breuer, S Dimmeler, S Zeiher, AM
Citation: S. Fichtlscherer et al., Elevated C-reactive protein levels and impaired endothelial vasoreactivityin patients with coronary artery disease, CIRCULATION, 102(9), 2000, pp. 1000-1006
Assessment of endothelial dysfunction in acute coronary syndromes
Authors: Fichtlscherer, S Zeiher, AM
Citation: S. Fichtlscherer et Am. Zeiher, Assessment of endothelial dysfunction in acute coronary syndromes, HERZ, 24(7), 1999, pp. 534-543
Risultati: 1-8 |